How to Use Tesamorelin: 2026 Research Guide

By the end of this guide you will know how to identify and verify a Tesamorelin 20 pen before research use, how to convert a target quantity into clicks using Veyvora’s 2026 reference values, and how to reconcile the arithmetic discrepancy between the stated per-click figure and the nominal label quantity.

Using Tesamorelin 20 for laboratory research requires four steps: confirm the batch number against the certificate of analysis (COA), verify the pen delivers 67 µg per click across 300 clicks, calculate the click count for your reference amount, and keep the material within a strictly in-vitro research workflow with no human-use claims attached [1].

How to use Tesamorelin 20 for in-vitro laboratory research:

1. Confirm the batch number printed on the pen matches the batch number on the COA before any research use.
2. Verify the pen specification: Tesamorelin 20 is a 3 mL, 300-click format delivering 67 µg per click [1].
3. Calculate the click count for your reference amount using the 67 µg-per-click figure (see the conversion table in the dosing section below).
4. Reconcile the arithmetic total (67 µg × 300 clicks = 20.1 mg) against the labelled nominal quantity and the COA-reported measured quantity.
5. Store and handle the pen according to the cold-chain conditions confirmed at the time of dispatch [1].
6. Record all batch details, click calculations and storage conditions in your laboratory documentation before recording any results.

Tesamorelin 20 pen specification (2026 reference values) [1]

Parameter	Value
Product name	Tesamorelin 20
Nominal quantity	20 mg
Format	3 mL pen
Clicks per pen	300
Dose per click	67 µg
Arithmetic total	20.1 mg (67 µg × 300)

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue used as a research peptide in in-vitro laboratory research. Veyvora’s Tesamorelin 20 pen lists 67 µg per click and 300 clicks per pen as its 2026 reference values [1]. Every figure in this guide is a reference value derived from Veyvora’s documented product information; none constitutes an instruction for human administration.

---

Key Takeaways

• Tesamorelin 20 is a 3 mL, 300-click pen delivering 67 µg per click, giving an arithmetic total of 20.1 mg, 0.1 mg above the nominal label figure due to rounding in the per-click value.
• The batch number on the pen barrel must match the batch number on the COA before any in-vitro work begins; a mismatch invalidates results recorded against that COA.
• Veyvora’s 2026 reference card lists three click counts: 15 clicks (≈1.005 mg), 23 clicks (≈1.541 mg), and 30 clicks (≈2.010 mg), each a whole-click approximation, not an exact milligram delivery.
• HPLC, mass spectrometry and endotoxin assay address different quality questions; none of the three, individually or combined, establishes potency retention after transit.
• All figures on this page are reference values for in-vitro laboratory research only.

---

How to Use Tesamorelin for Laboratory Research

To use Tesamorelin 20 in laboratory research, confirm research-use-only status first, then match the batch number to the COA, inspect the packaging and gel pack on arrival, convert your reference amount into clicks using the 67 µg-per-click figure from Veyvora’s 2026 product documentation, and record all batch details before logging any result [1].

This page does not provide instructions for administration to people or animals. All reference values are for in-vitro laboratory research only.

Research-use workflow, Tesamorelin 20 (2026):

1. Confirm research-use-only status. Verify that your protocol designates Tesamorelin 20 as a research reagent and that no human- or animal-use claims are attached to the workflow before the pen is opened [1].
2. Match the product and batch number. Check that the batch number printed on the pen barrel matches the batch number on the COA, a mismatch invalidates any result recorded against that COA [1].
3. Inspect the packaging and gel pack. On receipt, check that the insulated bag and gel ice pack are intact and that the parcel still feels cold before disturbing the carton. Veyvora ships cold in an insulated bag with a gel ice pack; a warm parcel or compromised packaging warrants quarantining the batch and notifying the supplier before use [1].
4. Convert the reference amount into clicks without premature rounding. Using Veyvora’s stated 67 µg per click, divide your target quantity in micrograms by 67 to obtain the exact click count before rounding to the nearest whole click [1]. For the mechanism behind the 67 µg figure, see Tesamorelin: the GHRH analogue explained.
5. Record batch details, handling conditions and protocol version. Log the batch number, COA reference, storage temperature, click calculation and protocol version number in your laboratory documentation before recording any experimental result [1].

For guidance on what the high-performance liquid chromatography (HPLC) purity figure on the COA can and cannot confirm, see how HPLC purity is measured.

Tesamorelin 20: Identify the Pen Before Use

Tesamorelin 20 is a 3 mL multi-dose click pen containing a nominal 20 mg of tesamorelin, a synthetic GHRH analogue supplied as a research peptide for in-vitro laboratory research only. The “20” in the product name is a size descriptor indicating nominal quantity; the batch-specific COA, not the label name, controls confirmed identity and concentration [1].

Pen Specification at a Glance

The table below lists Veyvora’s 2026 page-stated specifications. Fields marked Verify must be checked against the current batch label and COA before recording results.

Specification	Value	Status
Product name	Tesamorelin 20	Page-stated [1]
Pen format	3 mL multi-dose click pen	Page-stated [1]
Nominal quantity	20 mg	Page-stated [1]
Total clicks per pen	300	Page-stated [1]
Micrograms per click	67 µg	Page-stated [1]
Supplied needles	31G 6 mm pen needles	Page-stated [1]
Printed dosing card	Included	Page-stated [1]
Batch number location	Pen barrel	Verify against COA
Research-use-only status	For in-vitro laboratory research only	Verify documentation
Concentration (inferred)	~6.67 mg/mL	Calculated; verify [1]

Veyvora’s Tesamorelin 20 pen lists 67 µg per click and 300 clicks per pen as its 2026 reference values, giving an arithmetic total of 20.1 mg [1]. That 0.1 mg difference from the labelled 20 mg nominal quantity reflects rounding in the per-click figure; the resolution procedure appears in the arithmetic discrepancy section below.

Before opening the pen, confirm that the batch number printed on the barrel matches the batch number on the COA, without that match, the COA cannot authenticate that pen’s identity or purity. For the full batch-number matching procedure, see verify a batch against its COA. For storage conditions and stability limits that apply once the pen is in use, see research-peptide storage and stability.

Tesamorelin Dosage Guide: Read the Reference Card

Veyvora’s 2026 Tesamorelin 20 reference card lists three amounts alongside their corresponding click counts: 1 mg at 15 clicks, 1.5 mg at 23 clicks, and 2 mg at 30 clicks [1]. Each figure is a reference value for in-vitro laboratory research only, not a protocol or recommendation for human administration.

Reference Schedule Table

The table below reproduces the card’s displayed values, shows the arithmetic result at 67 µg per click, and flags where rounding means the calculated amount differs from the nominal label figure.

Reference amount	Displayed clicks	Arithmetic at 67 µg per click	Difference from nominal	Status
1 mg	15	15 × 67 µg = 1,005 µg (1.005 mg)	+0.005 mg	Reference material only [1]
1.5 mg	23	23 × 67 µg = 1,541 µg (1.541 mg)	+0.041 mg	Reference material only [1]
2 mg	30	30 × 67 µg = 2,010 µg (2.010 mg)	+0.010 mg	Reference material only [1]

Reconcile these arithmetic conversions of Veyvora’s 2026 reference values with the current batch documentation before recording results [1].

Why the Click Counts Are Rounded

The 1 mg row is the most precise: 1,000 µg ÷ 67 µg = 14.93 clicks, which rounds to 15. The 1.5 mg row shows the largest nominal gap: 1,500 µg ÷ 67 µg = 22.39 clicks, rounded up to 23, producing 1,541 µg rather than exactly 1,500 µg, a 2.7% overshoot relative to the nominal label figure. The 2 mg row gives 2,000 µg ÷ 67 µg = 29.85 clicks, rounded to 30, yielding 2,010 µg.

These differences arise because 67 µg does not divide evenly into round milligram amounts. The printed card presents the nearest whole-click approximation; the arithmetic result is what the pen actually delivers at that click count, assuming the per-click volume is consistent across the barrel.

Precedence Rule

The printed dosing card and the current batch COA take precedence over any figure reproduced here. Where the card supplied with a specific pen states a different per-click value, recalculate every row using that figure before logging results. For definitions of terms such as assay purity and endotoxin that appear on the COA, the research peptide glossary provides batch-documentation context. Tesamorelin 20 sits within Veyvora’s Growth & Recovery research pens catalogue category, where batch documentation for the current stock is listed alongside the product.

Tesamorelin Dosing Instructions: Convert Clicks Safely

To convert a target quantity into pen clicks, apply this formula: clicks = target quantity in µg ÷ µg per click. For Veyvora’s Tesamorelin 20, the stated per-click output is 67 µg [1]. Convert milligrams to micrograms first (1 mg = 1,000 µg), then divide, then round to the nearest whole click and record the unrounded result separately.

Step-by-Step Conversion

1. Confirm the per-click output from the printed dosing card supplied with the pen: 67 µg per click for Tesamorelin 20 [1].
2. Convert your target quantity to micrograms: multiply milligrams by 1,000 (e.g. 1 mg = 1,000 µg).
3. Divide: 1,000 µg ÷ 67 µg per click = 14.93 clicks (unrounded).
4. Round to the nearest whole click: 15 clicks.
5. Run the reverse check: 15 clicks × 67 µg = 1,005 µg, confirming a 5 µg overshoot relative to the 1,000 µg target.
6. Log both the unrounded result (14.93) and the rounded click count (15) in your research record, along with the batch number and the per-click figure used.
7. Label every entry as arithmetic based on 2026 Veyvora product information, not a dosing recommendation.

Worked Example: 1 mg Reference Quantity

At 67 µg per click, 1 mg (1,000 µg) requires 14.93 clicks, rounded to 15 [1]. Those 15 clicks deliver approximately 1,005 µg, a 0.5% overshoot that arises because 67 µg does not divide evenly into 1,000 µg, so the nearest whole click count overshoots the target. Reconcile this arithmetic conversion with the current batch COA before recording results [1].

Critical Assumption: This Figure Is Pen-Specific

The 67 µg per-click output is specific to Veyvora’s Tesamorelin 20 pen [1]. A different pen format, a different fill volume, or a different manufacturer’s click mechanism will produce a different per-click output, so never carry the 67 µg figure across to another product without verifying the corresponding dosing card and batch documentation. For the mechanism behind tesamorelin as a GHRH analogue, including published-evidence context, see Veyvora’s dedicated research page.

Check the Batch Before Recording Results

Verify the Tesamorelin 20 batch against its COA before any material enters an in-vitro laboratory research workflow. Complete the following steps in order, recording each outcome in your research log:

1. Photograph the unopened carton, capturing the printed batch number, expiry date and any tamper-evident seal.
2. Record the batch number from the carton label in your research log before opening.
3. Download or request the batch-specific COA from Veyvora; a vendor page stating “COA on request” is not equivalent to a downloaded, batch-matched document [3].
4. Confirm the product name on the COA reads “Tesamorelin 20” and that the batch number matches the carton exactly, a single-character mismatch is grounds to pause and contact the supplier [3].
5. Inspect the mass spectrometry identity result: this test confirms the molecular identity of the peptide by matching the measured mass to the expected value for tesamorelin; it does not, on its own, confirm purity or concentration [3].
6. Review the HPLC assay result: Veyvora states a threshold of at least 98.0% assay purity for its 2026 batches, tested first by Asterion Analytics and then again by Veyvora’s own internal testing [1]. HPLC supports composition and purity assessment but does not establish long-term stability or confirm molecular identity independently of mass spectrometry [3].
7. Review the endotoxin assay result: this test addresses endotoxin contamination and should report the assay method, the result and the applicable limit; it does not substitute for identity or purity testing [3].
8. Check the synthesis-partner traceability field on the COA. Veyvora operates as a reseller; the COA should identify the manufacturing synthesis partner separately, confirming the chain of custody from production to dispatch [1].
9. Log any mismatch between batch numbers, test results and stated thresholds, or missing fields, before using the material, and do not proceed until mismatches are resolved with the supplier.

What Each Test Can and Cannot Establish

Veyvora’s 2026 quality-control process uses HPLC, mass spectrometry and endotoxin assay, conducted first by Asterion Analytics and then again by Veyvora’s own internal testing [1]. These three tests address different questions: HPLC assesses purity and peak profile; mass spectrometry confirms molecular identity; endotoxin assay screens for contamination. None of the three, individually or combined, establishes potency retention after transit or long-term shelf-life, only a validated stability study can determine that.

For the detailed batch-number matching procedure that this guide summarises, see Veyvora’s verify a batch against its COA page. For handling guidance after the receiving check, see research-peptide storage and stability.

Handle the Pen and Cold Chain Correctly

Inspect and record the condition of every Tesamorelin 20 pen at the point of receipt, before the material enters any research workflow. Veyvora’s 2026 commercial documentation states that pens are dispatched cold in an insulated bag with a gel ice pack, usually within 24 hours of order; confirm the current dispatch terms directly with Veyvora before ordering, as commercial conditions may change [1].

Use the following receiving workflow in order:

1. Inspect the outer carton for visible damage, crushing or moisture ingress before opening. Photograph any damage and note it in the batch log.
2. Check the insulated gel packing is intact and that the gel pack has not fully thawed; a fully liquid pack indicates a potential thermal excursion.
3. Confirm the parcel is still cold immediately on opening. A parcel that no longer feels cold, or an insulated bag or gel pack that has been compromised, does not by itself confirm potency loss, but it requires the excursion to be logged and the supplier notified before the material is used.
4. Record arrival condition in writing: date received, batch number visible on the pen, whether the parcel felt cold, and gel-pack state.
5. Transfer the pen to 2–8 °C storage in line with the current product documentation, and do not leave the pen at ambient temperature for longer than the supplier’s stated handling window.
6. Keep the pen identified by batch number throughout storage; do not pool pens from different batches in the same storage location without clear labelling.
7. Inspect needle integrity before each research use: confirm the 31G 6 mm pen needles are sealed, undamaged and within their stated shelf-life, and do not attach a needle until the moment of use in the research protocol.

Why Temperature History Matters

The condition of the insulated packaging and gel pack on arrival indicates whether the cold chain may have been broken in transit; it cannot establish degradation kinetics, potency retention or shelf-life [1]. Only a validated stability study can do that, so treat a warm parcel or compromised packaging as grounds to classify the batch as unverified for research purposes until the supplier provides a stability-qualified assessment or a replacement batch.

For terminology used in this receiving workflow, see Veyvora’s research peptide glossary. For the full catalogue context of Tesamorelin 20, see Growth & Recovery research pens.

Resolve the 20 mg Arithmetic Discrepancy

The arithmetic is straightforward: 67 µg × 300 clicks = 20,100 µg, which equals 20.1 mg [1]. That 0.1 mg excess over the nominal “20” in the product name is small, but it is not trivial for auditable research records. Before logging any reference amount, reconcile three sources, the current batch label, the printed dosing card and the COA, to confirm which figure governs.

Why the Numbers Diverge

Three distinct mechanisms can produce a gap between a displayed per-click figure and a nominal label quantity:

1. Rounding in the displayed click output. The true per-click delivery may be, say, 66.7 µg, with the card rounding to 67 µg; that rounding inflates the apparent total by approximately 0.1 mg across 300 clicks.
2. Nominal versus net fill. A 20 mg label may describe nominal content; the actual fill volume may be slightly higher to account for dead volume in the pen mechanism, meaning the usable delivered amount differs from both the label and the click-arithmetic total.
3. Batch-to-batch variation within specification. A COA reporting a measured quantity above or below the nominal label value is not automatically a defect; it may fall within the supplier’s stated acceptance range. Without the Veyvora batch-specific COA in hand, which figure applies to a given pen remains unverified.

None of these explanations can be confirmed from the web-page figures alone [1].

Three-Way Reconciliation Checklist

Run this check before recording any reference amount against a batch:

1. Read the batch label on the pen: note the stated nominal quantity in mg.
2. Read the printed dosing card: confirm the per-click figure (67 µg as of 2026 [1]) and the total click count (300 clicks [1]).
3. Multiply: 67 µg × 300 = 20,100 µg = 20.1 mg, record this as the arithmetic implied total, not as the verified net content.
4. Compare the arithmetic total against the COA net-content result for that batch number.
5. Where the three figures align within the COA’s stated tolerance, document the reconciliation and proceed.
6. Where any figure conflicts, contact the supplier before use and log the discrepancy.

Red flag: Do not overwrite the batch COA or label with a rounded web-page figure. The COA is the primary quality record; a product-page number is a reference convenience, not a batch-specific measurement [1].

At 67 µg per click, 300 clicks imply 20.1 mg, a 2026 arithmetic conversion of Veyvora’s stated reference values, not proof of net content [1]. For a fuller explanation of what the HPLC purity result on a COA can and cannot establish, see how HPLC purity is measured.

What This Reference Schedule Can and Cannot Show

A printed reference schedule standardises a click count and timing for documentation purposes; it does not establish peptide identity, confirm batch stability, validate an assay, or predict a result.

What the Schedule Does

Veyvora’s 2026 dosing card records a per-click figure (67 µg [1]) and a total click count (300 [1]) so that a researcher can document a consistent reference amount across experiments. That consistency is the card’s only function: it gives a reproducible starting point for record-keeping, not a protocol.

What the Schedule Cannot Do

The reference card cannot substitute for the following, each of which the researcher must establish independently:

• Identity confirmation, only mass spectrometry on the specific batch can confirm the peptide is tesamorelin and not a related GHRH analogue fragment.
• Purity and potency, HPLC reports a peak-area ratio for that batch on that test date; it does not project stability forward or confirm activity in a given assay system.
• Stability under experimental conditions, no validated stability study for the exact Veyvora Tesamorelin 20 format has been identified in available 2026 sources; the condition of the insulated packaging and gel pack on arrival indicates transit handling only, not degradation kinetics [1].
• Assay suitability, in-vitro researchers must define their own controls, endpoints and acceptance criteria; those are protocol decisions, not reference-card outputs.
• Human-outcome claims, published clinical studies on tesamorelin used defined populations, routes and endpoints under regulated conditions; those findings describe those studies, not the properties of a research reagent.

Before recording any result against a batch, verify a batch against its COA to confirm that the batch number, HPLC result and identity data align with the pen in hand. For handling requirements after receipt, research-peptide storage and stability covers the deeper guidance that a receiving checklist alone cannot supply.

A reference schedule is a documentation tool [1]. The experimental validity of any result depends on the researcher’s validated protocol, not on the card.

Tesamorelin 20 Availability and Next Steps

Researchers based in the United Kingdom can order Tesamorelin 20 directly through Veyvora, which dispatches to the UK, Germany, Czechia, Spain, Portugal and South Africa as of 2026 [1].

Ordering Details

Field	Confirmed detail
Price (GBP)	Check the current Tesamorelin 20 product listing, live price unconfirmed at time of writing
Stock status	Check the current product listing, not confirmed in available 2026 sources
Eligible markets	UK, Germany, Czechia, Spain, Portugal, South Africa [1]
Currencies accepted	GBP, EUR, CZK, ZAR [1]
Dispatch time	Typically within 24 hours [1]
Cold-chain packaging	Insulated bag with a gel ice pack [1]
Purchase restriction	Research use only, not for human administration
Batch COA access	Available on request; batch number must match the pen in hand [1]

Before First Use

Veyvora’s documented quality-control process requires that the batch number printed on the pen is reconciled against the COA before any in-vitro work begins. Confirm the HPLC purity result, mass-spectrometry identity confirmation and endotoxin value are all present on the batch-specific document [3].

Unfamiliar with terms such as HPLC purity, endotoxin assay or lyophilised material? The research peptide glossary defines each in the context of laboratory reagent handling.

Verify your batch against its COA before recording any result, that single step is the minimum audit trail for defensible in-vitro research.

Sources

[1] Veyvora, research peptides, measured to the microgram, veyvora.com, https://veyvora.com/ [3] Veyvora, verify your batch against its COA, veyvora.com, https://veyvora.com/testing/verify-your-batch